Concepedia

Shripad Chitnis

SC

8

Publications

385

Citations

8

H-Index

2010

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

University of Rhode Island

University of Colorado Denver

Novartis (China)

Shripad Chitnis is an author at Novartis (United States) specializing in medicine, pharmacology, and hematology.

Top concepts

Publications per year

2010–2024

8

Publications

8

CRISPR-Cas9 Editing of the <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell Disease

Akshay Sharma, Jaap Jan Boelens, Maria Cancio et al. · New England Journal of Medicine · 2023 · 138 citations · Full text

Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients

K. OGASAWARA, Shripad Chitnis, Reginald Gohh et al. · Clinical Pharmacokinetics · 2013 · 81 citations · Full text

, , +8

A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction

Pamela Y. Ting, Sneha Borikar, John Ryan Kerrigan et al. · Science · 2024 · 65 citations

, , +20

Modelling the Sitagliptin Effect on Dipeptidyl Peptidase-4 Activity in Adults with Haematological Malignancies After Umbilical Cord Blood Haematopoietic Cell Transplantation

Nieves Vélez de Mendizábal, Robert Matthew Strother, Sherif S. Farag et al. · Clinical Pharmacokinetics · 2013 · 31 citations · Full text

, , +11

Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism

Shripad Chitnis, K. OGASAWARA, Björn Schniedewind et al. · Xenobiotica · 2013 · 29 citations · Full text

Rows per page

1–5 of 8